Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.

Alexander Stojadinovic1, Axel Hoos, Aviram Nissan

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Human Pathology
|February 28, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis.

Human vaccines & immunotherapeutics·2024
Same author

Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study.

Frontiers in psychology·2023
Same author

Real-world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non-small cell lung cancer in the EU5.

Thoracic cancer·2023
Same author

Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026.

Future oncology (London, England)·2023
Same author

The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies.

Cancer investigation·2023
Same author

The most likely but largely ignored triggering factor for breast (or all) cancer invasion.

Journal of Cancer·2023

Parathyroid carcinoma is an aggressive cancer that often recurs and has a poor prognosis. Molecular markers like Ki-67 and p27 can help distinguish it from benign parathyroid adenomas.

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Parathyroid adenomas are benign tumors, while parathyroid carcinomas are rare but aggressive malignancies.
  • Distinguishing between adenomas and carcinomas is crucial for patient management and prognosis.

Purpose of the Study:

  • To investigate the clinical, pathological, and molecular differences between parathyroid adenomas and carcinomas.
  • To identify potential molecular markers for differentiating parathyroid carcinoma from adenoma.

Main Methods:

  • Analysis of clinical and histopathological data from patients with parathyroid adenomas and carcinomas.
  • Immunohistochemical analysis of molecular markers including Ki-67, p53, mdm2, p21, Bcl-2, cyclin D1, and p27 on tissue microarrays.

Related Experiment Videos

Main Results:

  • Parathyroid carcinomas exhibited characteristic invasion (vascular, capsular, soft-tissue) and a high recurrence rate (74%) with a 5-year survival of 50%.
  • High Ki-67 expression was more frequent in carcinomas (25%) than adenomas (2%), while p27 expression was higher in adenomas (80%) than carcinomas (18%).
  • A specific molecular phenotype (p27(+)Bcl-2(+)Ki-67(-)mdm2(+)) was observed in adenomas but not in carcinomas, with increasing molecular complexity correlating with tumor aggressiveness.

Conclusions:

  • Parathyroid carcinoma is an aggressive malignancy with a propensity for recurrence and poor outcomes.
  • Ki-67 and p27 expression levels, along with specific molecular phenotypes, can aid in differentiating parathyroid carcinoma from adenoma.
  • Molecular marker analysis offers valuable insights into tumor aggressiveness and can guide diagnosis.